Controversies in Breast Cancer Screening Strategies

J Natl Compr Canc Netw. 2016 May;14(5 Suppl):651-3. doi: 10.6004/jnccn.2016.0183.


A panel discussion on controversies in breast cancer screening held recently at the NCCN 21st Annual Conference included only a few controversies. Representatives of the U.S. Preventive Services Task Force, American Cancer Society, and NCCN disagreed primarily on 2 main areas: when to start screening (ages 40, 45, or 50 years) and frequency of screening (annual vs biennial). Panelists from these organizations presented the rationales for their respective recommendations.

MeSH terms

  • Breast Neoplasms / diagnosis*
  • Early Detection of Cancer
  • Female
  • Humans
  • Mass Screening / methods*
  • Middle Aged